NASDAQ:KMDA

Kamada Ltd. Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Drug Manufacturers—Specialty & Generic

$4.91

-0.149 (-2.94%)

At Close: Jun 20, 2024

Kamada Ltd. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 KMDA shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Kamada Ltd.

Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurre... KMDA Profile

Golden Star

Ticker	Date	Change	Price
RGA	Jun 17	1.84%	$203.90
MA	Jun 17	0.98%	$448.11
EPD	Jun 17	0.740%	$28.37
BR	Jun 17	1.16%	$197.65
^DJI	Jun 17	0.92%	38,778.10 points
SARK	Jun 17	1.85%	$30.34
DRI	Jun 14	3.70%	$148.78
AXNX	Jun 14	0.179%	$67.20
BXSL	Jun 14	0.0319%	$31.33
RSG	Jun 13	2.35%	$187.43

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In